SZLSF SZLSF

Stagezero Life Sciences (QB) Stock Price

0.0529
0.00 (0.0%)
0.0529
Volume 0.00
Bid Price 0.05
Ask Price 0.061
News -
Day High

Low
0.0529

52 Week Range

High
0.25

Day Low
Company Name Stock Ticker Symbol Market Type
Stagezero Life Sciences Ltd (QB) SZLSF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0529 09:05:20
Open Price Low Price High Price Close Price Prev Close
0.0529
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.0529 - 0.25
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0529 USD

Period:

Draw Mode:

Stagezero Life Sciences Ltd (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.33M 100.73M 63.80M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
8.40k $ - - - -

more financials information »

Stagezero Life Sciences (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SZLSF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.05290.05290.05290.052920,0000.000.0%
1 Month0.060950.060950.05290.05690719,140-0.00805-13.21%
3 Months0.062650.062650.05290.05673898,566-0.00975-15.56%
6 Months0.06740.085850.05290.06604127,357-0.0145-21.51%
1 Year0.24930.250.05290.12433457,984-0.1964-78.78%
3 Years0.3490.43390.05290.214474110,352-0.2961-84.84%
5 Years0.3490.43390.05290.214474110,352-0.2961-84.84%

Stagezero Life Sciences (QB) Description

StageZero Life Sciences is dedicated to the early detection of multiple diseases through whole blood tests. The Company's next-generation test, Aristotle, is the first-ever multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. StageZero's full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups, and the Company operates a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia. In addition, leveraging its specialty in polymerase chain reaction (PCR) testing for the early identification of cancer through blood, StageZero also provides both COVID PCR testing (swab and saliva) and blood test analysis (Antibody testing).